Immunovant Inc. Common Stock (IMVT) Stock Price Today
Key Stats
- $5.96BMarket Cap
- 1,057,999Volume
- HealthSector
- $44.9652W High
- $21.6552W Low
- 20 DaysTypical Hold Time
- $5.06BEnterprise Value
- -Div Yield
- -Trading Activity
Track Immunovant Inc. Common Stock (IMVT) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Immunovant Inc. Common Stock has traded between a low of $21.65 and a high of $44.96, highlighting its annual price range. Buy and sell Immunovant Inc. Common Stock shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Most Recent News
Global music market to grow at 8.07% CAGR, reaching $57.74B by 2032 driven by streaming and digital access.
The global music market is projected to grow from $36.13 billion in 2026 to $57.74 billion by 2032, at a CAGR of 8.07%, fueled by paid streaming subscriptions, smartphone adoption, and digital music discovery. North America remains the largest market...

Palladium ETF faces decline amid EV demand threat and supply surplus forecast for 2027.
The abrdn Physical Palladium Shares ETF is expected to underperform due to structural challenges from the rise of electric vehicles, which reduce demand for palladium in autocatalytic converters. The ETF has dropped about 36% year-to-date and nearly ...

China's coffee market to reach $8.04B by 2032, driven by cafe culture and specialty coffee growth.
China's coffee market is projected to grow from $5.8 billion in 2026 to $8.04 billion by 2032, at a CAGR of 5.54%. Growth is fueled by expanding chain cafes, specialty coffee methods like cold brew, and rising homegrown brands. However, rising coffee...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.